Literature DB >> 24906841

Outcome measures in stapes surgery: postoperative results are independent from preoperative parameters.

Mario Koopmann1, Daniel Weiss, Eleftherios Savvas, Claudia Rudack, Markus Stenner.   

Abstract

The aim of this study was to compare audiometric results before and after stapes surgery and identify potential prognostic factors to appropriately select patients with otosclerosis who will most likely benefit from surgery. We enrolled 126 patients with otosclerosis (162 consecutive ears) in our study who underwent stapes surgery between 2007 and 2012 at our institution. Preoperative and postoperative data including pure-tone audiometry, speech audiometry, stapedial reflex audiometry and surgical data were analyzed. The average preoperative air-bone gap (ABG) was 28.9 ± 8.6 dB. Male patients and patients older than 45 years of age had greater preoperative ABGs in comparison to females and younger patients. Postoperative ABGs were 11.2 ± 7.4 dB. The average ABG gain was 17.7 ± 11.1 dB. Preoperative audiometric data, age, gender and type of surgery did not influence the postoperative results. Stapes surgery offers predictable results independent from disease progression or patient-related factors. While absolute values of hearing improvement are instrumental in reflecting audiometric results of a cohort, relative values better reflect individual's audiometric data resembling the patient's benefit.

Entities:  

Mesh:

Year:  2014        PMID: 24906841     DOI: 10.1007/s00405-014-3113-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  Factors affecting hearing results after stapes surgery.

Authors:  H Ueda; T Miyazawa; K Asahi; N Yanagita
Journal:  J Laryngol Otol       Date:  1999-05       Impact factor: 1.469

2.  Smoking and tympanoplasty: implications for prognosis and the Middle Ear Risk Index (MERI).

Authors:  Z Becvarovski; J M Kartush
Journal:  Laryngoscope       Date:  2001-10       Impact factor: 3.325

Review 3.  The aetiology of otosclerosis: a review of the literature.

Authors:  D J Menger; R A Tange
Journal:  Clin Otolaryngol Allied Sci       Date:  2003-04

4.  Active middle ear implant application in case of stapes fixation: a temporal bone study.

Authors:  Arnaud Devèze; Kanthaiah Koka; Stéphane Tringali; Herman A Jenkins; Daniel J Tollin
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

5.  Long-term results in otosclerotic patients operated by stapedectomy or stapedotomy.

Authors:  O Spandow; O Söderberg; L Bohlin
Journal:  Scand Audiol       Date:  2000

6.  Effect of the stapedotomy technique on early post-operative hearing results--Preliminary results.

Authors:  Tino Just; Ellen Guder; Hans Wilhelm Pau
Journal:  Auris Nasus Larynx       Date:  2011-08-20       Impact factor: 1.863

7.  Prognostic factors of long-term outcomes after ossiculoplasty using multivariate analysis.

Authors:  Yasuo Mishiro; Masafumi Sakagami; Tadashi Kitahara; Chieko Kakutani
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-01       Impact factor: 2.503

8.  Transient depression of inner ear function after stapedotomy: skeeter versus CO(2) laser technique.

Authors:  T Somers; J P Vercruysse; A Zarowski; M Verstreken; I Schatteman; F E Offeciers
Journal:  Adv Otorhinolaryngol       Date:  2007

9.  Outcome and lack of prognostic factors in stapes surgery.

Authors:  Jean-Marc Gerard; Paul Serry; Michel C Gersdorff
Journal:  Otol Neurotol       Date:  2008-04       Impact factor: 2.311

10.  Long term outcome of otosclerosis surgery.

Authors:  Maria Teresa Bernardo; Joana Dias; Daniela Ribeiro; Diamantino Helena; Artur Condé
Journal:  Braz J Otorhinolaryngol       Date:  2012 Jul-Aug
View more
  1 in total

1.  Long-term hearing results of stapedotomy: analysis of factors affecting outcome.

Authors:  Ingeborg Dhooge; Stéphanie Desmedt; Thomas Maly; David Loose; Helen Van Hoecke
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-16       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.